BR9909732A - Gene codificando proteìna de interação com sintaxina - Google Patents
Gene codificando proteìna de interação com sintaxinaInfo
- Publication number
- BR9909732A BR9909732A BR9909732-0A BR9909732A BR9909732A BR 9909732 A BR9909732 A BR 9909732A BR 9909732 A BR9909732 A BR 9909732A BR 9909732 A BR9909732 A BR 9909732A
- Authority
- BR
- Brazil
- Prior art keywords
- gene
- syntaxin
- new
- protein
- interaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Patente de Invenção:<B>"GENE CODIFICANDO PROTEìNA DE INTERAçãO COM SINTAXINA"<D>. A presente invenção refere-se a novos genes e polipeptídios derivados dos mesmos, codificando uma proteína de interação com sintaxina. A invenção também descreve vetores e células hospedeiras compreendendo o novo gene. A invenção descreve ainda métodos para usar o novo gene, polipeptídios e anticorpos especificamente alvejando polipeptídios derivados dos novos genes, na detecção de deleções genéticas do gene, localização subcelular do polipeptídio, isolamento de classes distintas de RNA, aplicações em terapia genética, diagnósticos para síndromes envolvendo resistência à insulina, desenvolvimento de estratégias de rastreamento registrado para inibidores de proteína de interação com sintaxina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8245498P | 1998-04-20 | 1998-04-20 | |
PCT/US1999/008568 WO1999054465A2 (en) | 1998-04-20 | 1999-04-19 | Gene encoding syntaxin interacting protein |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9909732A true BR9909732A (pt) | 2000-12-19 |
Family
ID=22171326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9909732-0A BR9909732A (pt) | 1998-04-20 | 1999-04-19 | Gene codificando proteìna de interação com sintaxina |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1071771A2 (pt) |
JP (1) | JP2002512031A (pt) |
KR (1) | KR20010042834A (pt) |
AU (1) | AU769825B2 (pt) |
BR (1) | BR9909732A (pt) |
CA (1) | CA2326623A1 (pt) |
NZ (2) | NZ526016A (pt) |
WO (1) | WO1999054465A2 (pt) |
ZA (1) | ZA200005845B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503756B1 (en) | 2000-09-22 | 2003-01-07 | Isis Pharmaceuticals, Inc. | Antisense modulation of syntaxin 4 interacting protein expression |
US20050014264A1 (en) * | 2002-12-11 | 2005-01-20 | University Of Massachusetts | Method of introducing siRNA into adipocytes |
FR2890859B1 (fr) * | 2005-09-21 | 2012-12-21 | Oreal | Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045436A2 (en) * | 1997-04-10 | 1998-10-15 | Genetics Institute, Inc. | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
-
1999
- 1999-04-19 NZ NZ526016A patent/NZ526016A/en unknown
- 1999-04-19 JP JP2000544797A patent/JP2002512031A/ja active Pending
- 1999-04-19 WO PCT/US1999/008568 patent/WO1999054465A2/en not_active Application Discontinuation
- 1999-04-19 CA CA002326623A patent/CA2326623A1/en not_active Abandoned
- 1999-04-19 BR BR9909732-0A patent/BR9909732A/pt not_active IP Right Cessation
- 1999-04-19 EP EP99918680A patent/EP1071771A2/en not_active Withdrawn
- 1999-04-19 KR KR1020007011597A patent/KR20010042834A/ko not_active Application Discontinuation
- 1999-04-19 NZ NZ507640A patent/NZ507640A/en unknown
- 1999-04-19 AU AU36535/99A patent/AU769825B2/en not_active Ceased
-
2000
- 2000-10-19 ZA ZA200005845A patent/ZA200005845B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NZ526016A (en) | 2004-10-29 |
WO1999054465A2 (en) | 1999-10-28 |
JP2002512031A (ja) | 2002-04-23 |
AU3653599A (en) | 1999-11-08 |
EP1071771A2 (en) | 2001-01-31 |
AU769825B2 (en) | 2004-02-05 |
ZA200005845B (en) | 2002-04-19 |
WO1999054465A9 (en) | 2000-01-27 |
WO1999054465A3 (en) | 2000-03-02 |
KR20010042834A (ko) | 2001-05-25 |
CA2326623A1 (en) | 1999-10-28 |
NZ507640A (en) | 2003-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Abramovich et al. | A protein‐arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor | |
Li et al. | Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA | |
Bomar et al. | Structure of the ubiquitin‐binding zinc finger domain of human DNA Y‐polymerase η | |
Koc et al. | A new face on apoptosis: death‐associated protein 3 and PDCD9 are mitochondrial ribosomal proteins | |
Tscherne et al. | Purification, cloning, and characterization of the 16S RNA m5C967 methyltransferase from Escherichia coli | |
BR0316435A (pt) | Produtos genéticos expressos diferencialmente em tumores e uso dos mesmos | |
DE69534733D1 (de) | NEUARTIGE AUF p53 ANSPRECHENDE GENE | |
DE69840361D1 (de) | Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme | |
DK0941318T5 (da) | Håndvægtformede konstruerede ekspressionssystemer til genterapi | |
Gu et al. | Identification of the 16S rRNA m5C967 methyltransferase from Escherichia coli | |
Bardy et al. | Archaeal signal peptides—a comparative survey at the genome level | |
HUP0203340A2 (hu) | Stressz-, rezisztencia- és toleranciafehérjéket kódoló Corynebacterium glutamicum gének | |
Lyons et al. | Detection of tRNA-like structure through RNase P cleavage of viral internal ribosome entry site RNAs near the AUG start triplet | |
Rogers et al. | tRNA anticodon shifts in eukaryotic genomes | |
BR0314512A (pt) | Célula hospedeira recombinante procariótica, método para a produção de um plasmìdeo, plasmìdeo e método para a detecção de uma mutação de cópia plasmìdea | |
DK1261718T3 (da) | Corynebacterium glutamicum gener, der koder for stofskiftepathwayproteiner | |
Rathi et al. | Genome subtraction for novel target definition in Salmonella typhi | |
Duggan et al. | Two DNA-binding sites on the globular domain of histone H5 are required for binding to both bulk and 5 S reconstituted nucleosomes | |
Knight et al. | Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis. | |
Arsène et al. | Role of region C in regulation of the heat shock gene-specific sigma factor of Escherichia coli, ς32 | |
ATE175239T1 (de) | Sialidase defiziente zellen | |
BR9909732A (pt) | Gene codificando proteìna de interação com sintaxina | |
Pedone et al. | A single point mutation (Glu85Arg) increases the stability of the thioredoxin from Escherichia coli | |
BR0214542A (pt) | Célula hospedeira, sistema de expressão, e, processos de preparação de uma célula hospedeira, e de uma proteìna alvo | |
Valente et al. | Translational features of human alpha 2b interferon production in Escherichia coli |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |